Ageeth Panman

Ageeth Panman

Kandidaat-notaris | Senior Associate

Contact

+31 10 217 25 23
+31 6 4239 5337

Languages

Dutch
English

Sectors

Follow me

Ageeth specialises in company law and mergers and acquisitions, focusing on areas such as advising on the company law aspects of restructurings, private acquisitions, management buy-outs, joint ventures, management and employee participation, and corporate governance. She advises a range of international and national clients in different sectors and has extensive experience with private equity transactions. Before joining Houthoff in 2009, Ageeth worked at the Dutch office of Simmons & Simmons for nine years. She is also a member of the Royal Dutch Association of Civil-law Notaries.

QUALIFICATIONS & EXPERIENCE

  • Grotius Academy specialisation course on Corporate Structures
  • LL.M. Notarial Law (University of Groningen)
  • Houthoff represented Active Capital Company in the sale of FTNON, a Netherlands-based manufacturer of food processing equipment specialized for the fresh cut and thermal treatment of fruit and vegetables, to JBT Corporation, a US-based leading global technology solutions provider to high-value segments of the food processing and air transportation industries. FTNON's USA and China based subsidiaries were, as part of this transaction, sold directly to JBT.

  • Houthoff represented Active Capital Company in their acquisition of Lumat International from their previous owners. Lumat is a supplier of High Tenacity Yarn, Polyester, Polyamide, (Nylon), Aramide and Synthetic continuous filament yarn.

  • Houthoff (co-counsel to Kirkland&Ellis and Dechert LLP, M&A, VDD) advised Wyndham Worldwide Corp on the sale of its European vacation rental business (Landal part) to private equity firm Platinum Equity for approximately USD1.3 billion. This matter is particularly significant/complex because of the multi cross border VDD exercise which Houthoff coordinated for the Landal part of the transaction with multiple park concepts and the very significant real estate component due to the large number of parks operated by Landal over the various jurisdiction (85 in total). We further advised on the competition aspects of various bidders and coordinate and advise on the Dutch works council advice procedure. The client is a NY stock exchange-listed American hospitality company.

  • Houthoff represented Sandd in the acquisition of Van Straaten Post from its previous owners. The combined group is able to service the 24-, 48- and 72- hours postal market throughout the work week with national coverage. The acquisition is part of Sandd’s strategy to become a real alternative on the Dutch postal market.

  • Thermo Fisher Scientific Inc., the world leader in serving science, acquired Phenom-World, a leader in desktop scanning electron microscopy (SEM) solutions. Thermo Fisher will integrate the business into Thermo Fisher's Analytical Instruments segment. Based in Eindhoven, the Netherlands, Phenom-World delivers desktop SEMs, and imaging and analysis packages, for research and industrial markets. The addition of Phenom World's leading desktop SEM platform strengthens Thermo Fisher's leadership in electron microscopy and expands the company's entry-level and desktop SEMs offerings for customers working in the materials science, industrial manufacturing, life sciences and electronics industries.

  • Houthoff advised Active Capital Company on the acquisition of a 70% majority stake in the capital of Arnold Suhr, the world's second largest trader in quinine. Arnold Suhr supplies quinine to soda producers such as Coca Cola and Schweppes for the production of tonic. In addition to quinine, Arnold Suhr is a worldwide trader in raw materials such as stevia and iodine for the food and beverage, sport nutrition and pharmaceutical industry.
  • Houthoff advised Active Capital Company on its acquisition of all shares in the capital of Codi Group B.V. (previously Cogitandum B.V.), a producer and distributor of nonwovens for personal care, household and the medical industry also known as 'wet-wipes'.
  • Advised Media-Saturn-Group, Europe’s number one consumer electronics retailer, on the acquisition of a majority stake in Dutch flash sales and live shopping platform iBOOD.com.
  • Houthoff advised Active Capital Company (ACC) on the acquisition, together with COO Martin den Ottolander, of Lantor, a company producing non-wovens for the cable and composite industry, from British IPT Group.
  • Dutch machine producer Food Technology Noord-Oost Nederland BV (Ftnon) has bought a 51% stake in Dutch robot maker Lacquey. The sum of the takeover was not disclosed, but was financed by Active Capital, which owns Ftnon. Houthoff advised Active Capital Company.
  • Royal IHC has acquired SAS Offshore, which is based in Alphen aan den Rijn, The Netherlands. SAS Offshore is specialised in designing and manufacturing high quality deck equipment for the offshore oil and gas market. This acquisition enables IHC to further secure its position as a supplier of reliable integrated offshore systems and integrated vessels in this sector.
    Royal IHC furthermore acquired a majority stake in Brastec Technologies, based in Brazil. Brastec Technologies designs and builds value-added, tailor-made production lines for the production of umbilicals and flexible pipes. This transaction fulfils two important elements of IHC business strategy: a foothold in the important Brazilian market; and the acquisition of Dutch-based SAS Offshore, which was fully owned by Brastec Technologies.

    Houthoff advised IHC on this transaction, together with a team from Machado Meyer Sendacz Opice.
  • Harbour BioMed, a newly established cancer therapies company based in Shanghai, today announced it has bought Harbour Antibodies BV for cash and an equity stake in Harbour Biomed in order to form a new oncology biotech.

    The acquisition was financed by Harbour BioMed investors, Advantech Capital and Legend Capital, two leading China-focused investors with a particular emphasis on life sciences.

    Harbour BioMed was established in 2016 with an initial financing of USD 50m from Advantech Capital, Legend Capital and the Harbour BioMed founding team. The company is headquartered with R&D operations in Shanghai, business operations in Cambridge, MA, and antibody platform innovation operations in Rotterdam, The Netherlands. The company plans to expand its presence in the Boston area by establishing a drug discovery innovation center.

    Houthoff assisted Erasmus MC Holding B.V., Atlas Holding Fund IX Coöperatief U.A. and the other shareholders of Harbour Antibodies B.V.
  • Sale of all shares in the capital of Regenboog Participaties B.V., ultimate parent of the BMC Group to Yacht Group Nederland B.V., subsidiary of Randstad.

Publications